Saha, P; Sandhu, V; Robinson, H; Ezeonyeji, A; Al-Shakarchi, I; Chander, S; Suresh, R; Kaul, A; Sofat, N (2020) Developing a pathway for tocilizumab treatment in giant cell arteritis: a South London regional experience. In: British Society for Rheumatology Annual Conference 2020, RHEUMATOLOGY.
SGUL Authors: Sofat, Nidhi

Microsoft Word (.docx) Accepted Version Available under License ["licenses_description_publisher" not defined]. Download (22kB)

Item Type:	Conference or Workshop Item (UNSPECIFIED)
Additional Information:	This is a pre-copyedited, author-produced version of an article accepted for publication in Rheumatology following peer review. The version of record Pratyasha Saha, Virinderjit Sandhu, Helena Robinson, Amara Ezeonyeji, Israa Al-Shakarchi, Sumeet Chander, Resmy Suresh, Arvind Kaul, Nidhi Sofat, P184 Developing a pathway for tocilizumab treatment in giant cell arteritis: a South London regional experience, Rheumatology, Volume 59, Issue Supplement_2, April 2020, keaa111.179 is available online at: https://doi.org/10.1093/rheumatology/keaa111.179
Keywords:	Arthritis & Rheumatology, 1103 Clinical Sciences, 1107 Immunology, 1117 Public Health and Health Services
SGUL Research Institute / Research Centre:	Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title:	RHEUMATOLOGY
Article Number:	keaa111.179
ISSN:	1462-0324
Dates:	Date Event 20 April 2020 Published 29 January 2020 Accepted
Publisher License:	Publisher's own licence
URI:	https://openaccess.sgul.ac.uk/id/eprint/111884
Publisher's version:	https://doi.org/10.1093/rheumatology/keaa111.179

Actions (login required)

Edit Item